Clinical Characteristics of Kawasaki Disease in Children with Different Age
Groups: A Literature Review and Retrospective Study

Baoying      Huang; Weiping      Tan; Shan      Liao; Wei      Jiang

doi:10.2174/1381612829666230609162009

Abstract

Background and Objective: Kawasaki disease (KD) is an acute self-limiting systemic vascular disease commonly observed in children less than 5 years of age. The present study comparatively assesses the clinical characteristics of children diagnosed with KD in different age groups. Furthermore, a comprehensive literature review on the clinical features and diagnostic guidelines of KD is performed.

Methods: This was a retrospective study conducted on the data of KD children admitted to the Sun Yat-Sen Memorial Hospital, Guangzhou, China, from January 2016 to December 2018. The children were divided into 3 age groups, including children < 1 year of age (group A, n = 66), 1-5 years of age (group B, n = 74), and children > 5 years of age (group C, n = 14). Complete clinical evaluation, hematological, and cardiovascular assessments were conducted and compared between the three groups.

Results: The time of diagnosis, hemoglobin, and neutrophil ratio of children in group A were significantly lower than the other two groups (p < 0.05), while the platelet count was significantly higher (p < 0.05). The proportion of incomplete KD (iKD) was the greatest in group A (40.9%), while the proportion of children with increased coronary Z value and aseptic meningitis was greater than that in group B (p < 0.0167). Group A showed less patients with KD shock syndrome (KDSS) than the other two groups (p < 0.05). Group B showed the greatest number of patients with arthralgia compared to the other two groups (p < 0.05). Three groups showed no significant difference to intravenous immunoglobulin (IVIG) therapy (p > 0.05).

Conclusion: The younger the age of KD onset, the more atypical the conditions are, with a greater risk of affecting other systems and a higher incidences of coronary artery disease. An early treatment with glucocorticoids might be helpful in older children and those with a greater high-risk KD warning score to prevent coronary injury.

« Previous Next »

[1]
Liu MY, Liu HM, Wu CH, et al. Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease. BMC Pediatr  2017; 17(1): 139.
 [http://dx.doi.org/10.1186/s12887-017-0895-8] [PMID: 28587647]

[2]
Tang Y, Gao X, Shen J, Sun L, Yan W. Epidemiological and clinical characteristics of Kawasaki disease and factors associated with coronary artery abnormalities in East China: Nine years experience. J Trop Pediatr  2016; 62(2): 86-93.
 [http://dx.doi.org/10.1093/tropej/fmv077] [PMID: 26884440]

[3]
Singh S, Jindal AK, Pilania RK. Diagnosis of Kawasaki disease. Int J Rheum Dis  2018; 21(1): 36-44.
 [http://dx.doi.org/10.1111/1756-185X.13224] [PMID: 29131549]

[4]
Chang FY, Hwang B, Chen SJ, Lee PC, Meng CCL, Lu JH. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J  2006; 25(3): 241-4.
 [http://dx.doi.org/10.1097/01.inf.0000202067.50975.90] [PMID: 16511387]

[5]
Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi  1967; 16(3): 178-222.
 [PMID: 6062087]

[6]
Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)--digest version. Circ J  2010; 74(9): 1989-2020.
 [http://dx.doi.org/10.1253/circj.CJ-10-74-0903] [PMID: 20724794]

[7]
Zhang MM, Shi L, Li XH, Lin Y, Liu Y. Clinical analysis of Kawasaki disease shock syndrome. Chin Med J (Engl)  2017; 130(23): 2891-2.
 [http://dx.doi.org/10.4103/0366-6999.219151] [PMID: 29176153]

[8]
Wright VJ, Herberg JA, Kaforou M, et al. Diagnosis of Kawasaki Disease using a minimal whole-blood gene expression signature. JAMA Pediatr  2018; 172(10): e182293.
 [http://dx.doi.org/10.1001/jamapediatrics.2018.2293] [PMID: 30083721]

[9]
Pezoulas VC, Papaloukas C, Veyssiere M, et al. A computational workflow for the detection of candidate diagnostic biomarkers of Kawasaki disease using time-series gene expression data. Comput Struct Biotechnol J  2021; 19: 3058-68.
 [http://dx.doi.org/10.1016/j.csbj.2021.05.036] [PMID: 34136104]

[10]
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation  2017; 135(17): e927-99.
 [http://dx.doi.org/10.1161/CIR.0000000000000484] [PMID: 28356445]

[11]
Ha S, Seo GH, Kim KY, Kim DS. Epidemiologic study on Kawasaki disease in Korea, 2007-2014: Based on health insurance review & assessment service claims. J Korean Med Sci  2016; 31(9): 1445-9.
 [http://dx.doi.org/10.3346/jkms.2016.31.9.1445] [PMID: 27510389]

[12]
Makino N, Nakamura Y, Yashiro M, et al. Epidemiological observations of Kawasaki disease in Japan, 2013-2014. Pediatr Int  2018; 60(6): 581-7.
 [http://dx.doi.org/10.1111/ped.13544] [PMID: 29498791]

[13]
Manlhiot C, O’Shea S, Bernknopf B, et al. Epidemiology of Kawasaki Disease in Canada 2004 to 2014: Comparison of surveillance using administrative data vs. periodic medical record review. Can J Cardiol  2018; 34(3): 303-9.
 [http://dx.doi.org/10.1016/j.cjca.2017.12.009] [PMID: 29395706]

[14]
Gradoux E, Di Bernardo S, Bressieux-Degueldre S, et al. Epidemiology of Kawasaki disease in children in Switzerland: a national prospective cohort study. Swiss Med Wkly  2022; 152(2122): w30171-1.
 [http://dx.doi.org/10.4414/SMW.2022.w30171] [PMID: 35748748]

[15]
Odingo M, Rutter M, Bowley J, et al. The incidence of Kawasaki disease using hospital admissions data for England 2006–2021. Rheumatology (Oxford)  2023; kead051.
 [http://dx.doi.org/10.1093/rheumatology/kead051] [PMID: 36715615]

[16]
Koliou MG, Aristidou A, Mazeri S, et al. Epidemiology and risk factors for resistance to treatment of Kawasaki disease in Cyprus. Sci Reports  2023; 131(13): 1-8.
 [http://dx.doi.org/10.1038/s41598-023-27694-1]

[17]
Fung SG, Webster R, Kuenzig ME, et al. Incidence of chronic immune-mediated inflammatory diseases after diagnosis with Kawasaki disease: a population-based cohort study. Rheumatology (Oxford)  2022; 61(5): 2095-103.
 [http://dx.doi.org/10.1093/rheumatology/keab680] [PMID: 34498025]

[18]
Rheumatology P, Alkanhal A, Saunders J, et al. Unexpectedly high incidence of Kawasaki disease in a Canadian Atlantic province- an 11-year retrospective descriptive study. Pediatr Rheumatol  2023; 211(21): 1-9.
 [http://dx.doi.org/10.1186/s12969-023-00805-y]

[19]
Shamsizadeh A, Ziaei Kajbaf T, Razavi M, Cheraghian B. Clinical and epidemiological characteristics of Kawasaki disease. Jundishapur J Microbiol  2014; 7(8): e11014.
 [http://dx.doi.org/10.5812/jjm.11014] [PMID: 25485046]

[20]
Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease Diagnostic criteria of cardiovascular lesions in Kawasaki disease 1983. Available from: ci.nii.ac.jp

[21]
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation  2004; 110(17): 2747-71.
 [http://dx.doi.org/10.1161/01.CIR.0000145143.19711.78] [PMID: 15505111]

[22]
Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int  2005; 47: 232-4.
 [http://dx.doi.org/10.1111/j.1442-200x.2005.02033.x] [PMID: 15771703]

[23]
Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics  2010; 125(2): e234-41.
 [http://dx.doi.org/10.1542/peds.2009-0606] [PMID: 20100771]

[24]
Peng Y, Liu X, Duan Z, Cai S, Duan J, Zhou Y. Age-related differences in clinical characteristics of Kawasaki disease. Braz J Med Biol Res  2021; 54(3): e10281.
 [http://dx.doi.org/10.1590/1414-431x202010281] [PMID: 33470389]

[25]
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent  2014; 81(3): 14-8.
 [PMID: 25951678]

[26]
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics  2004; 114(6): 1708-33.
 [http://dx.doi.org/10.1542/peds.2004-2182] [PMID: 15574639]

[27]
de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr  1998; 133(2): 254-8.
 [http://dx.doi.org/10.1016/S0022-3476(98)70229-X] [PMID: 9709715]

[28]
Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation  2006; 113(22): 2606-12.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.105.592865] [PMID: 16735679]

[29]
Chen JJ, Ma XJ, Liu F, et al. Epidemiologic features of Kawasaki disease in Shanghai from 2008 through 2012. Pediatr Infect Dis J  2016; 35(1): 7-12.
 [http://dx.doi.org/10.1097/INF.0000000000000914] [PMID: 26372452]

[30]
Lee KY, Hong JH, Han JW, Lee JS, Lee BC, Burgner D. Features of Kawasaki disease at the extremes of age. J Paediatr Child Health  2006; 42(7-8): 423-7.
 [http://dx.doi.org/10.1111/j.1440-1754.2006.00898.x] [PMID: 16898879]

[31]
Minich LL, Sleeper LA, Atz AM, et al. Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics  2007; 120(6): e1434-40.
 [http://dx.doi.org/10.1542/peds.2007-0815] [PMID: 18025079]

[32]
Li W, Zhang L, Huang P, Zhang Z. Clinical features and mid-term follow-up in infants younger than 3 months with Kawasaki disease in a Chinese population. J Paediatr Child Health  2019; 55(5): 523-7.
 [http://dx.doi.org/10.1111/jpc.14233] [PMID: 30246351]

[33]
Song D, Yeo Y, Ha K, et al. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr  2009; 168(11): 1315-21.
 [http://dx.doi.org/10.1007/s00431-009-0925-0] [PMID: 19159953]

[34]
Yoon YM, Yun HW, Kim SH. Clinical characteristics of Kawasaki disease in infants younger than six months: A single-center study. Korean Circ J  2016; 46(4): 550-5.
 [http://dx.doi.org/10.4070/kcj.2016.46.4.550] [PMID: 27482265]

[35]
Rosario JM, Patel F, Levasseur K, Adams L. Kawasaki at the extremes of age. Pediatr Emerg Care  2019; 35(12): e229-31.
 [http://dx.doi.org/10.1097/PEC.0000000000001991] [PMID: 31790071]

[36]
Zhao Q, Huang M, Huang M, Chen S, Liu F, Huang G. Characteristics and trends in diagnosis of Kawasaki disease outside the usual age range. Clin Rheumatol  2021; 40(4): 1515-23.
 [http://dx.doi.org/10.1007/s10067-020-05361-4] [PMID: 32845440]

[37]
Mărginean CO, Meliţ LE, Mărginean MO. The peculiarities of Kawasaki disease at the extremes of age. Medicine (Baltimore)  2019; 98(42): e17595.
 [http://dx.doi.org/10.1097/MD.0000000000017595] [PMID: 31626134]

[38]
Rowley AH, Shulman ST. Editorial commentary: missing the forest for the trees: respiratory viral assays in patients with kawasaki disease. Clin Infect Dis  2013; 56(1): 65-6.
 [http://dx.doi.org/10.1093/cid/cis811] [PMID: 23011146]

[39]
No SJ, Kim DO, Choi KM, Eun LY. Do predictors of incomplete Kawasaki disease exist for infants? Pediatr Cardiol  2013; 34(2): 286-90.
 [http://dx.doi.org/10.1007/s00246-012-0440-3] [PMID: 23001516]

[40]
Burns JC, Mason WH, Glode MP, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. J Pediatr  1991; 118(5): 680-6.
 [http://dx.doi.org/10.1016/S0022-3476(05)80026-5] [PMID: 2019921]

[41]
Hu F, Shi X, Fan Y, Liu H, Zhou K. Cerebrospinal fluid changes and clinical features of aseptic meningitis in patients with Kawasaki disease. J Int Med Res  2021; 49(2)
 [http://dx.doi.org/10.1177/0300060520980213] [PMID: 33530798]

[42]
Orenstein JM, Shulman ST, Fox LM, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One  2012; 7(6): e38998.
 [http://dx.doi.org/10.1371/journal.pone.0038998] [PMID: 22723916]

[43]
Qian W, Tang Y, Yan W, Sun L, Lv H. A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease. Ital J Pediatr  2018; 44(1): 33.
 [http://dx.doi.org/10.1186/s13052-018-0475-z] [PMID: 29523168]

[44]
Inoue Y, Okada Y, Shinohara M, et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcome. J Pediatr  2006; 149(3): 336-341.e1.
 [http://dx.doi.org/10.1016/j.jpeds.2006.05.025] [PMID: 16939743]

[45]
Kanegaye JT, Wilder MS, Molkara D, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics  2009; 123(5): e783-9.
 [http://dx.doi.org/10.1542/peds.2008-1871] [PMID: 19403470]

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1381612829666230609162009	Print ISSN 1381-6128
Publisher Name Bentham Science Publisher	Online ISSN 1873-4286

Current Pharmaceutical Design

Clinical Characteristics of Kawasaki Disease in Children with Different Age Groups: A Literature Review and Retrospective Study

Abstract Play Pause

Related Journals

Related Books

Abstract